Menu
Back to Journals » Psoriasis: Targets and Therapy » Volume 9
Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
Authors Chiricozzi A , De Simone C , Fossati B , Peris K
Received 30 July 2019
Accepted for publication 30 July 2019
Published 15 August 2019 Volume 2019:9 Pages 73—74
Chiricozzi A, De Simone C, Fossati B, Peris K. Psoriasis: Targets and Therapy. 2019;9:29–35.
The authors of this paper have advised us that by mistake they uploaded the wrong figure files for Figures 2 and 3 which had not been correctly updated.
Read the original article
© 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.